Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00185) | |||||
---|---|---|---|---|---|
Name |
Dexamethasone
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
dexamethasone; Decadron; Maxidex; Dexamethazone; Dexasone; Hexadrol; Oradexon; Prednisolone F; Cortisumman; Decaspray; Desametasone; Hexadecadrol; Millicorten; Auxiron; Calonat; Dexacort; Dexason; Fluormethylprednisolone; Aeroseb-Dex; Deltafluorene; Desamethasone; Mediamethasone; Superprednol; Visumetazone; Aphtasolon; Decaderm; Decasone; Dectancyl; Dekacort; Dergramin; Desadrene; Desameton; Dexacortal; Dexacortin; Dexadeltone; Dexalona; Dexameth; Dexapolcort; Dextelan; Dinormon; Fortecortin; Gammacorten; Mymethasone; Turbinaire; Corsone; Decalix; Dexone; Mexidex; Dexa-Cortidelt; Dexa-Cortisyl; Dexa-Scheroson; Prednisolon F; Aeroseb-D; SK-Dexamethasone; Anaflogistico; Decacortin; Deseronil; Dexafarma; Dexaprol; Dexinolon; Dexinoral; Loverine; Luxazone; Policort; Spoloven; Decagel; Deronil; Dezone; Sunia Sol D; Bisu DS; Dexa Mamallet; Hexadrol Elixir; Dexa-sine; Lokalison F; Isopto-Dex; Ocu-trol; Dex-ide; Hl-dex; Dexamethasonum; Dexone 4; Fluorocort; Decaject; Decameth; Fluormone; Corson; Dexpak; Pet Derm III; Dexamethasone alcohol; Hexadrol Tablets; Dexamethasone Intensol; Methylfluorprednisolone; Desametasone [DCIT]; Dexone 0.5; Dexone 1.5; Dexone 0.75; Dexametasona; Dexacidin; Maxitrol; Dexametasona [INN-Spanish]; Dexamethasonum [INN-Latin]; Decadron Tablets, Elixir; Azium (Veterinary); Dexamethansone; Ozurdex; Posurdex; Prodex; MK 125; C22H29FO5; OTO-104; (3H)-Dexamethasone; Azimycin (Veterinary); NSC 34521; Naquasone (Veterinary); Tresaderm (Veterinary); 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol; 16alpha-Methyl-9alpha-fluoroprednisolone; 16-alpha-Methyl-9-alpha-fluoroprednisolone; 9-alpha-Fluoro-16-alpha-methylprednisolone; UNII-7S5I7G3JQL; 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone; 9alpha-Fluoro-16alpha-methylprednisolone; delta1-9alpha-Fluoro-16alpha-methylcortisol; MFCD00064136; Decacort; Dexamethasone (DHAP); 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol; 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone; delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol; 9A-FLUORO-16BETA-METHYLPREDNISOLONE; 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone; 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone; 7S5I7G3JQL; CHEBI:41879; ISV-305; [3H]-dexamethasone; NSC-34521; Decaject-L.A.; Dexamethasone, 96%; Dexair; 16.alpha.-Methyl-9.alpha.-fluoroprednisolone; 9.alpha.-Fluoro-16.alpha.-methylprednisolone; Dexacen-4; 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol; 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone; Dextenza; Osurdex; Dexamethasone Base; Decadron (TN); SMR000857119; DXM [Steroid]; CCRIS 7067; HSDB 3053; dexamethasone (tetramethyl-rhodamine conjugated ); Prednisolone, 9.alpha.-fluoro-16.alpha.-methyl-; EINECS 200-003-9; Dexametasone; Solurex; .delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol; 16.alpha.-Methyl-9.alpha.-fluoro-.delta.(sup1)-hydrocortisone; Diodex; DexaSite; NSC34521; AI3-50934; .gamma.corten; Apo-dexamethasone; Prednisolone, 9alpha-fluoro-16alpha-methyl-; Dexasone 4mg; Zema-Pak; PHL-dexamethasone; PMS-dexamethasone; [3H]dexamethasone; Dexamethasone-omega; NCGC00091019-08; Dexasone 0.5mg; Dexamethasone [USP:INN:BAN:JAN]; Dexasone 0.75mg; Sandoz Dexamethasone; Dexamethasone, topical; Maxidex Ont 0.1%; Maxidex Sus 0.1%; dexamethasone-17-acetate; DSSTox_CID_384; Spectrum5_002019; MolMap_000018; 9-Fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione; SCHEMBL3774; DSSTox_RID_75557; BIDD:PXR0060; DSSTox_GSID_20384; BSPBio_000995; MLS001055412; MLS001332507; MLS001332508; ARONIS27003; BIDD:ER0494; sustained-release dexamethasone; CHEMBL384467; GTPL2768; GTPL3447; SGCUT00126; 9-Fluoro-16-methylprednisolone; Ak Dex Oph Otic Soln 0.1%; DTXSID3020384; BDBM18207; Dexamethasone (JP17/USP/INN); HMS1792A17; HMS1990A17; HMS2089N13; HMS2235F08; HMS3039L11; HMS3259N11; HMS3403A17; Dexamethasone Cyclodextrin complex; to_000038; ZINC3875332; Tox21_200122; Dexamethasone, >=97.0% (HPLC); IBI-10090; Dexamethasone 1.0 mg/ml in Methanol; PMS Dexamethasone Elixir 0.5mg/5ml; AKOS005259009; AKOS015895509; Decadron phosphate, Decdan, Dexacort,; ACN-036253; CCG-264887; CS-1505; DB01234; KS-1451; MCULE-4773827191; NC00645; alpha -Fluoro-16-alpha -methylcortisol; CAS-50-02-2; Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-16alpha-methyl-; SMP1_000092; Dexamethasone, >=98% (HPLC), powder; NCGC00091019-01; NCGC00091019-02; NCGC00091019-03; NCGC00091019-04; NCGC00091019-05; NCGC00091019-06; NCGC00091019-07; NCGC00091019-23; NCGC00257676-01; 23495-06-9; 9alpha-fluoro-16alpha-methyl-Prednisolone; AC-11056; HY-14648; NCI60_003067; SMR001227192; 16alpha -Methyl-9alpha -fluoroprednisolone; 9alpha -Fluoro-16alpha -methylprednisolone; AB0072035; Dexamethasone, tested according to Ph.Eur.; ST50307091; EN300-52607; 1793-EP2269977A2; 1793-EP2269989A1; 1793-EP2269990A1; 1793-EP2270008A1; 1793-EP2270014A1; 1793-EP2270018A1; 1793-EP2272832A1; 1793-EP2275420A1; 1793-EP2277565A2; 1793-EP2277566A2; 1793-EP2277567A1; 1793-EP2277568A2; 1793-EP2277569A2; 1793-EP2277570A2; 1793-EP2277861A1; 1793-EP2277865A1; 1793-EP2277876A1; 1793-EP2279741A2; 1793-EP2281563A1; 1793-EP2289894A2; 1793-EP2292227A2; 1793-EP2292280A1; 1793-EP2292589A1; 1793-EP2292614A1; 1793-EP2292617A1; 1793-EP2295055A2; 1793-EP2295402A2; 1793-EP2295409A1; 1793-EP2295412A1; 1793-EP2295413A1; 1793-EP2295416A2; 1793-EP2298731A1; 1793-EP2298743A1; 1793-EP2298748A2; 1793-EP2298764A1; 1793-EP2298765A1; 1793-EP2298772A1; 1793-EP2298778A1; 1793-EP2298779A1; 1793-EP2298780A1; 1793-EP2305248A1; 1793-EP2305642A2; 1793-EP2305663A1; 1793-EP2305689A1; 1793-EP2308562A2; 1793-EP2308812A2; 1793-EP2308833A2; 1793-EP2308839A1; 1793-EP2308880A1; 1793-EP2311453A1; 1793-EP2314585A1; 1793-EP2314590A1; 1793-EP2316459A1; 1793-EP2316832A1; 1793-EP2316833A1; 1793-EP2316834A1; 1793-EP2371811A2; C15643; D00292; Dexamethasone, meets USP testing specifications; J10029; Prednisolone, 9alpha -fluoro-16alpha -methyl-; W-5058; 9.alpha.-Fluoro-16.alpha.-methyl-1,20-dione; AB00918428-05; AB00918428-08; AB00918428-09; AB00918428_10; 064D136; 16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol; Dexamethasone, VETRANAL(TM), analytical standard; Q422252; Neomycin and polymyxin b sulphates and dexamethasone; Q-200939; BRD-K38775274-001-02-3; BRD-K38775274-001-06-4; 1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone; 9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione; Dexamethasone, British Pharmacopoeia (BP) Assay Standard; Z802671480; Pregna-1,4-diene-3,20-dione, 9-fluoro-11alpha -methyl-; Dexamethasone, European Pharmacopoeia (EP) Reference Standard; WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1; Dexamethasone, powder, BioReagent, suitable for cell culture, >=97%; Dexamethasone, United States Pharmacopeia (USP) Reference Standard; 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione; 4.alpha.-Fluoro-16.alpha.-methyl-11.beta.-17,4-diene-3,20-dione; 9a-Fluoro-11b,17a,21-trihydroxy-16a-methylpregna-1,4-diene-3,20-dione; Pregna-1,20-dione, 9-fluoro-11.beta.,17,21-trihydroxy-16.alpha.-methyl-; 9-Fluoro-11.beta.,21-trihydroxy-16.alpha.-methylpregna-1,4-diene-3,20-dione; 9-fluoro-16alpha-methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione; Dexamethasone, Pharmaceutical Secondary Standard; Certified Reference Material; 1050677-47-8
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Rheumatoid arthritis | ICD-11: FA20 | [1] | ||
PubChem CID | |||||
Formula |
C22H29FO5
|
||||
Canonical SMILES |
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C
|
||||
InChI |
1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1
|
||||
InChIKey |
UREBDLICKHMUKA-CXSFZGCWSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5743"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 392.5 | Topological Polar Surface Area | 94.8 | |
XlogP | 1.9 | Complexity | 805 | ||
Heavy Atom Count | 28 | Rotatable Bond Count | 2 | ||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Dexamethasone 6 mg tablet | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Anhydrous lactose; D&c yellow no. 10; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Anhydrous lactose; D&c yellow no. 10; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Croscarmellose sodium; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Sucrose; Fd&c green no. 3; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Avera McKennan Hospital; Physicians Total Care; West-Ward Pharmaceticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Dexamethasone 0.5 mg tablet | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Anhydrous lactose; D&c yellow no. 10; Fd&c yellow no. 5; Magnesium stearate; Croscarmellose sodium; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [3] | |||
Hydrazine yellow | DIG Info | GABA(A) receptor alpha-1 (IC50 = 13 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Fd&c yellow no. 6; Magnesium stearate; Sucrose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Physicians Total Care; West-Ward Pharmaceticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Dexamethasone 0.75 mg tablet | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Anhydrous lactose; D&c yellow no. 10; Fd&c blue no. 1; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions; H. J. Harkins Company | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Anhydrous lactose; D&c yellow no. 10; Fd&c blue no. 1; Magnesium stearate; Croscarmellose sodium; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Par Pharmaceutical; Preferred Pharamaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c blue no. 1; Magnesium stearate; Sucrose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions; Aidarex Pharmaceuticals; Bryant Ranch Prepack; PD-Rx Pharmaceuticals; Physicians Total Care; Rebel Distributors; West-Ward Pharmaceticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Dexamethasone 1.5 mg tablet | Click to Show/Hide the Full List of Formulation(s): 7 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c red no. 40; Fd&c blue no. 1; Magnesium stearate; Sucrose; Fd&c red no. 3; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Bryant Ranch Prepack; Lake Eire Medical & Surgical Supply DBA Quality Care Products; Physicians Total Care; West-Ward Pharmaceticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [2] | |||
FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Anhydrous lactose; Fd&c red no. 40; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Blenheim Phamacal | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [3] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Anhydrous lactose; Fd&c red no. 40; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | DirectRX | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [3] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Anhydrous lactose; Fd&c red no. 40; Magnesium stearate; Croscarmellose sodium; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Xspire Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [3] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Anhydrous lactose; Fd&c red no. 40; Magnesium stearate; Croscarmellose sodium; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [3] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Maltodextrin; Magnesium stearate; Sucrose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Larken Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [5] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | ECR Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Dexamethasone 4 mg tablet | Click to Show/Hide the Full List of Formulation(s): 5 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Fd&c yellow no. 6; Magnesium stearate; Sucrose; Fd&c green no. 3; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions; Bryant Ranch Prepack; Dispensing Solution; Lake Eire Medical & Surgical Supply DBA Quality Care Products; PD-Rx Pharmaceuticals; Physicians Total Care; Proficient Rx; Rebel Distributors; Stat Rx USA; West-Ward Pharmaceticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Fd&c yellow no. 6; Magnesium stearate; Sucrose; Fd&c green no. 3; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Cardinal Health | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Anhydrous lactose; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions; Aidarex Pharmaceuticals; Blenheim Phamacal; H. J. Harkins Company; NuCare Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Anhydrous lactose; Magnesium stearate; Croscarmellose sodium; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | NuCare Pharmaceuticals; Par Pharmaceutical; Preferred Pharamaceuticals; RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Anhydrous lactose; Magnesium stearate; Croscarmellose sodium; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | RedPharm | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Dexamethasone 1 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Sucrose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Rebel Distributors; West-Ward Pharmaceticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Dexamethasone 2 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Sucrose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions; PD-Rx Pharmaceuticals; Physicians Total Care; Proficient Rx; Rebel Distributors; West-Ward Pharmaceticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.